首页> 外国专利> Fused aminodihydrothiazine derivatives and pharmaceutical compositions comprising them for use in the treatment of alzheimer-type dementia and down's syndrome

Fused aminodihydrothiazine derivatives and pharmaceutical compositions comprising them for use in the treatment of alzheimer-type dementia and down's syndrome

机译:融合的氨基二氢噻嗪衍生物和包含它们的药物组合物,用于治疗阿尔茨海默氏型痴呆和唐氏综合症

摘要

A compound represented by the general formula (I): a pharmaceutically acceptable salt thereof, or a solvate of the compound or salt has an A² production inhibitory activity or BACE 1 inhibitory activity, and is thus useful as an agent for treating neurodegenerative diseases caused by A² as typified by Alzheimer's disease. In the formula, ring A represents a C 6-14 aryl group or the like; L represents -NR 1 CO- (wherein R L represents a hydrogen atom or the like) or the like; ring B represents a C 6-14 aryl group or the like; X represents a C 1-3 alkylene group or the like; Y represents a C 1-3 alkylene group or the like; Z represents an oxygen atom or the like; R 1 and R 2 each independently represents a hydrogen atom or the like; and R 3 , R 4 , R 5 and R 6 each independently represents a hydrogen atom, a halogen atom or the like.
机译:通式(I)表示的化合物:其药学上可接受的盐或该化合物或盐的溶剂化物具有A 2产生抑制活性或BACE 1抑制活性,因此可用作治疗由A 2引起的神经退行性疾病的药物,以阿尔茨海默氏病为代表。式中,环A表示碳数6〜14的芳基等。 L表示-NR 1 CO-(其中RL表示氢原子等)等。环B表示碳数6〜14的芳基等。 X表示碳数1〜3的亚烷基等。 Y表示碳数1〜3的亚烷基等。 Z表示氧原子等; R 1和R 2各自独立地表示氢原子等。 R 3,R 4,R 5和R 6分别独立地表示氢原子,卤素原子等。

著录项

  • 公开/公告号IL211933A

    专利类型

  • 公开/公告日2015-03-31

    原文格式PDF

  • 申请/专利权人 EISAI R& D MANAGEMENT CO. LTD.;

    申请/专利号IL20110211933

  • 发明设计人

    申请日2011-03-24

  • 分类号C07D;

  • 国家 IL

  • 入库时间 2022-08-21 15:15:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号